This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Agha-Hosseini F, Moosavi MS, Sadrzadeh Afshar MS, Sheykhbahaei N. Assessment of the relationship between stress and oral lichen planus: a review of literature. J Islam Dent Assoc Iran. 2016; 28:78–85.Agha-HosseiniFMoosaviMSSadrzadeh AfsharMSSheykhbahaeiNAssessment of the relationship between stress and oral lichen planus: a review of literature201628788510.30699/jidai.29.2.78Search in Google Scholar
Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar M-S. Evaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review. J Contemp Dent Pract. 2016; 17:692–701.Agha-HosseiniFSheykhbahaeiNSadrZadeh-AfsharM-SEvaluation of potential risk factors that contribute to malignant transformation of oral lichen planus: a literature review20161769270110.5005/jp-journals-10024-1914Search in Google Scholar
Boorghani M, Gholizadeh N, Zenouz AT, Vatankhah M, Mehdipour M. Oral lichen planus: clinical features, etiology, treatment and management; a review of literature. J Dent Res Dent Clin Dent Prospect. 2010; 4:3–9. doi: 10.5681/joddd.2010.002BoorghaniMGholizadehNZenouzATVatankhahMMehdipourMOral lichen planus: clinical features, etiology, treatment and management; a review of literature201043910.5681/joddd.2010.002Open DOISearch in Google Scholar
Katne T, Muppirala AVS, Devaraju RR, Gantala R. A potent regimen for oral lichen planus: a review. Ann Essence Dentist. 2017; 9:7c–11c. doi: 10.5368/aedj.2017.9.2.3.2KatneTMuppiralaAVSDevarajuRRGantalaRA potent regimen for oral lichen planus: a review201797c11c10.5368/aedj.2017.9.2.3.2Open DOISearch in Google Scholar
Yarnell E, Abascal K. Herbal treatment for lichen planus. Altern Complement Ther. 2010; 16:217–22.YarnellEAbascalKHerbal treatment for lichen planus2010162172210.1089/act.2010.16408Search in Google Scholar
Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007; 28:521–74.StraubRHThe complex role of estrogens in inflammation2007285217410.1210/er.2007-0001Search in Google Scholar
Ahmed SA. The immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field. Toxicology. 2000; 150:191–206.AhmedSAThe immune system as a potential target for environmental estrogens (endocrine disrupters): a new emerging field200015019120610.1016/S0300-483X(00)00259-6Search in Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014; 12:1495–9.von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE initiativeThe Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies2014121495910.1097/EDE.0b013e318157765418049194Search in Google Scholar
Seriolo B, Cutolo M, Garnero A, Accardo S. Relationships between serum 17 β-oestradiol and anticardiolipin antibody concentrations in female patients with rheumatoid arthritis. Rheumatology (Oxford). 1999; 38:1159–61.SerioloBCutoloMGarneroAAccardoSRelationships between serum 17 β-oestradiol and anticardiolipin antibody concentrations in female patients with rheumatoid arthritis19993811596110.1093/rheumatology/38.11.115910556275Search in Google Scholar
Tengstrand B, Carlström K, Felländer-Tsai L, Hafström I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol. 2003; 30:2338–43.TengstrandBCarlströmKFelländer-TsaiLHafströmIAbnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation200330233843Search in Google Scholar
Calabrese EJ. Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol. 2001; 31:503–15.CalabreseEJEstrogen and related compounds: biphasic dose responses2001315031510.1080/2001409111178511504177Search in Google Scholar
Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 1999; 103:282–8.KandaNTamakiKEstrogen enhances immunoglobulin production by human PBMCs1999103282810.1016/S0091-6749(99)70503-8Search in Google Scholar
Verheul H, Schot L, Schuurs H. Therapeutic effects of nandrolone decanoate, tibolone, lynestrenol and ethylestrenol on Sjögren's syndrome-like disorder in NZB/W mice. Clin Exp Immunol. 1986; 64:243–8.VerheulHSchotLSchuursHTherapeutic effects of nandrolone decanoate, tibolone, lynestrenol and ethylestrenol on Sjögren's syndrome-like disorder in NZB/W mice1986642438Search in Google Scholar
MacKenzie-Graham AJ, Rinek GA, Avedisian A, Morales LB, Umeda E, Boulat B, et al. Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis. J Neurosci Res. 2012; 90:1310–23.MacKenzie-GrahamAJRinekGAAvedisianAMoralesLBUmedaEBoulatBEstrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis20129013102310.1002/jnr.23019335061422411609Search in Google Scholar
Vandenbroucke JP, Witteman JC, Valkenburg HA, Boersma JW, Cats A, Festen JJ, et al. Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA. 1986; 255:1299–303.VandenbrouckeJPWittemanJCValkenburgHABoersmaJWCatsAFestenJJNoncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women1986255129930310.1001/jama.1986.03370100093024Search in Google Scholar
Gholizadeh N, Poorfar HK, Taghavi Zenouz A, Vatandoost M, Mehdipour M. Comparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls. Iran J Pathol. 2015; 10:136–40.GholizadehNPoorfarHKTaghavi ZenouzAVatandoostMMehdipourMComparison of serum autoantibodies to desmogleins I, III in patients with oral lichen planus and healthy controls20151013640Search in Google Scholar
Ansar Ahmed S, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect. 1999; 107(Suppl 5):681–6.Ansar AhmedSHissongBDVerthelyiDDonnerKBeckerKKarpuzoglu-SahinEGender and risk of autoimmune diseases: possible role of estrogenic compounds1999107Suppl 5681610.1289/ehp.99107s5681156625010502531Search in Google Scholar
Losordo DW, Isner JM. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol. 2001; 21:6–12.LosordoDWIsnerJMEstrogen and angiogenesis: a review20012161210.1161/01.ATV.21.1.6Search in Google Scholar
Cutolo M, Capellino S, Sulli A, Serioli B, Secchi ME, Villaggio B, Straub RH. Estrogens and autoimmune diseases. Ann N Y Acad Sci. 2006; 1089:538–47.CutoloMCapellinoSSulliASerioliBSecchiMEVillaggioBStraubRHEstrogens and autoimmune diseases200610895384710.1196/annals.1386.04317261796Search in Google Scholar
Rider V, Jones SR, Evans M, Abdou NI. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol. 2000; 95:124–34.RiderVJonesSREvansMAbdouNIMolecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells2000951243410.1006/clim.2000.484410779406Search in Google Scholar
Vohra S, Singal A, Sharma SB. Clinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial. Int J Dermatol. 2016; 55:101–5.VohraSSingalASharmaSBClinical and serological efficacy of topical calcineurin inhibitors in oral lichen planus: a prospective randomized controlled trial201655101510.1111/ijd.1288726147635Search in Google Scholar